A Retrospective Real-World Study Evaluating Safety Of Novel Oral Anticoagulants (NOACs) Versus Vitamin K Antagonist:A District General Hospital Experience.
Phase of Trial: Phase IV
Latest Information Update: 16 Jan 2017
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Vitamin K antagonists
- Indications Stroke; Thromboembolism
- Focus Adverse reactions
- 16 Jan 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.